Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • Amitriptyline HCl: Technical Guide for Neuropharmacology Wor

    2026-06-05

    Amitriptyline HCl: Technical Guide for Neuropharmacology Workflows

    What This Product Solves

    Amitriptyline HCl, also known as 3-(5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine hydrochloride, is a tricyclic compound designed for reliable inhibition of key neurotransmitter receptors. It is widely used in neuropharmacology research to dissect serotonin, norepinephrine, 5-HT4, 5-HT2, and sigma-1 receptor-mediated pathways. Its high analytical purity (≥98% by HPLC and NMR) and robust solubility profiles make it particularly valuable for in vitro and in vivo assays requiring precise modulation of neurotransmitter signaling. In contexts such as mood disorder research, neurodegenerative disease model systems, and neurotransmitter receptor modulation workflows, Amitriptyline HCl provides a reproducible, well-characterized reagent for investigating cellular and molecular mechanisms under defined conditions. For details on validated benchmarks and receptor modulation protocols, see this internal article. For workflow-specific troubleshooting and optimization, refer to this technical guide.

    Protocol Parameters

    • Assay: Receptor inhibition
      Value: IC50 (Serotonin receptor): 3.45 nM
      Applicability: In vitro receptor binding and functional antagonism studies
      Rationale: Enables precise quantification of serotonin receptor modulation at nanomolar concentrations
      Source Type: product information
    • Assay: Stock solution preparation
      Value: Solubility ≥15.69 mg/mL in DMSO, ≥43.9 mg/mL in water, ≥50 mg/mL in ethanol
      Applicability: Preparation of concentrated stocks for cell-based or biochemical assays
      Rationale: High solubility facilitates workflow flexibility and compatibility with aqueous or organic-based protocols
      Source Type: product information
    • Assay: Storage conditions
      Value: Solid at -20°C; use solutions immediately after preparation
      Applicability: Ensures compound integrity for neuropharmacology research and receptor modulation studies
      Rationale: Prevents degradation or loss of potency during storage; adheres to best practice for small molecule inhibitors
      Source Type: product information
    • Assay: Solution handling (workflow recommendation)
      Value: Prepare fresh working dilutions; avoid freeze-thaw cycles
      Applicability: Optimized for cell culture, tissue slice assays, or in vivo administration
      Rationale: Maintains reproducibility and minimizes the risk of hydrolysis or oxidation
      Source Type: Workflow recommendation

    Workflow Setup and QC Checklist

    • Stock Preparation: Dissolve Amitriptyline HCl in DMSO, water, or ethanol at recommended concentrations. Use calibrated balances and pre-certified solvents to ensure accurate dosing. Filter-sterilize if required for cell culture applications.
    • Aliquoting: Dispense individual-use aliquots to minimize freeze-thaw exposure. Label each aliquot with compound name, concentration, date, and storage conditions.
    • Storage: Store solid material at -20°C in a desiccated environment. Avoid exposure to light, moisture, and repeated warming events.
    • Solution Use: Prepare working solutions immediately before experimental application. Discard unused solutions after each session to prevent compound breakdown.
    • Purity Verification: Reference lot-specific HPLC and NMR data as provided on the Amitriptyline HCl product page. For critical experiments, confirm batch integrity with in-house analytical QC.
    • Documentation: Record all compound lot numbers, preparation protocols, and handling steps in laboratory notebooks to support data reproducibility.

    Common Failure Modes and Fixes

    • Unexpected Loss of Activity: Often due to prolonged storage of diluted solutions or repeated freeze-thaw cycles. Fix: Always prepare fresh working dilutions and avoid storing solutions for later use.
    • Precipitation in Stock Solutions: May result from exceeding solubility limits or using incompatible solvents. Fix: Confirm solvent compatibility before preparation; if precipitation occurs, gently warm and vortex to dissolve, but do not exceed recommended temperatures.
    • Variable Assay Response: Inconsistent pipetting, solvent evaporation, or light exposure can reduce reliability. Fix: Employ calibrated pipettes, minimize open-vessel handling, and protect from light throughout all workflows.
    • Contamination: Compound or solution contamination can arise from non-sterile handling. Fix: Use sterile equipment and aseptic technique, especially for cell-based assays.

    Scope and Limitations

    Amitriptyline HCl is specifically optimized for experimental modulation of serotonin, norepinephrine, 5-HT4, 5-HT2, and sigma-1 receptors in neuropharmacology and mood disorder research. Its application is best suited to in vitro and in vivo workflows where reproducible receptor inhibition is required. The compound is not formulated for long-term solution storage, nor is it validated for mechanistic exploration outside of its primary neurotransmitter targets. Users should avoid employing Amitriptyline HCl in experimental domains lacking established receptor relevance or in protocols demanding extended solution stability. For expanded technical guidance and use cases, see the detailed technical guidance article.

    Conclusion

    Amitriptyline HCl (SKU B2231) serves as a robust, high-purity tool for precise neurotransmitter receptor modulation in neuropharmacology research. Adherence to recommended preparation, storage, and QC steps is essential for maximizing data reliability and experimental reproducibility. See the Amitriptyline HCl product page for up-to-date batch specifications and further handling instructions. By following these technical guidelines, researchers can confidently apply Amitriptyline HCl in mood disorder and neurodegenerative disease model systems while maintaining full control over performance variables.